Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT04241835
Title A Study of Oral Tazemetostat in Subjects With Moderate and Severe Hepatic Impairment With Advanced Malignancies
Recruitment Recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors Epizyme, Inc.
Indications

Advanced Solid Tumor

hematologic cancer

Therapies

Tazemetostat

Age Groups: senior | adult
Covered Countries USA | FRA | BEL


No variant requirements are available.